Ki‐Hye Kim

1.7k total citations
76 papers, 1.3k citations indexed

About

Ki‐Hye Kim is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Ki‐Hye Kim has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Epidemiology, 45 papers in Immunology and 18 papers in Infectious Diseases. Recurrent topics in Ki‐Hye Kim's work include Respiratory viral infections research (49 papers), Influenza Virus Research Studies (43 papers) and Immune Cell Function and Interaction (32 papers). Ki‐Hye Kim is often cited by papers focused on Respiratory viral infections research (49 papers), Influenza Virus Research Studies (43 papers) and Immune Cell Function and Interaction (32 papers). Ki‐Hye Kim collaborates with scholars based in United States, South Korea and Canada. Ki‐Hye Kim's co-authors include Sang‐Moo Kang, Young‐Tae Lee, Eun‐Ju Ko, Youri Lee, Yu‐Jin Jung, Young‐Man Kwon, Hye Suk Hwang, Yu-Jin Kim, Yuna Lee and Min Chul Kim and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

Ki‐Hye Kim

75 papers receiving 1.3k citations

Peers

Ki‐Hye Kim
Comparison fields: 5 of 95
  • Epidemiology 804
  • Immunology 526
  • Infectious Diseases 381
  • Molecular Biology 350
  • Pulmonary and Respiratory Medicine 125
Young‐Man Kwon United States
Fang Fang China
Young‐Tae Lee United States
Andreas Grassauer Austria
Dae‐Goon Yoo United States
Ravi Tandon India
Joon‐Yong Bae South Korea
Makoto Ohwaki Japan
Eun-Ha Kim South Korea
Mohsan Ullah Goraya China
Young‐Man Kwon United States View profile →
Citations per field, relative to Ki‐Hye Kim
Ki‐Hye Kim · 1×
Citations per year, relative to Ki‐Hye Kim
Ki‐Hye Kim · 1×

Countries citing papers authored by Ki‐Hye Kim

Since Specialization
Citations

This map shows the geographic impact of Ki‐Hye Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ki‐Hye Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ki‐Hye Kim more than expected).

Fields of papers citing papers by Ki‐Hye Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ki‐Hye Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ki‐Hye Kim. The network helps show where Ki‐Hye Kim may publish in the future.

Co-authorship network of co-authors of Ki‐Hye Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ki‐Hye Kim. A scholar is included among the top collaborators of Ki‐Hye Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ki‐Hye Kim. Ki‐Hye Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination Journal of Virology Ki‐Hye Kim, Rong Liu et al. 1
2 Interferon-γ receptor signaling is critical for balanced immune activation and protection against influenza after vaccination Virology Ki‐Hye Kim, Hye Suk Hwang et al. 0
3 Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants Vaccines Rong Liu, Janhavi P. Natekar et al. 3
4 Supplementation of seasonal vaccine with multi-subtype neuraminidase and M2 ectodomain virus-like particle improves protection against homologous and heterologous influenza viruses in aged mice Antiviral Research Ki‐Hye Kim, Rong Liu et al. 7
5 Metabolic reprograming and increased inflammation by cadmium exposure following early-life respiratory syncytial virus infection: the involvement of protein S-palmitoylation Toxicological Sciences Choon‐Myung Lee, Ki‐Hye Kim et al. 7
6 Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination Vaccines Ki‐Hye Kim, Subbiah Jeeva et al. 6
7 A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine npj Vaccines Subbiah Jeeva, Ki‐Hye Kim et al. 23
8 Thermostable H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A viruses Molecular Therapy — Methods & Clinical Development Ki‐Hye Kim, Chong Hyun Shin et al. 5
9 Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses Virology Subbiah Jeeva, Ki‐Hye Kim et al. 2
10 Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination Vaccines Ki‐Hye Kim, Subbiah Jeeva et al. 5
11 BCG Cell Wall Skeleton As a Vaccine Adjuvant Protects Both Infant and Old-Aged Mice from Influenza Virus Infection Biomedicines Ki‐Hye Kim, Young‐Tae Lee et al. 6
12 An Update on mRNA-Based Viral Vaccines Vaccines Subbiah Jeeva, Ki‐Hye Kim et al. 23
13 Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice Vaccines Ki‐Hye Kim, Subbiah Jeeva et al. 11
14 Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome Cells Chong Hyun Shin, Ki‐Hye Kim et al. 5
15 Adjuvant effects of killed Lactobacillus casei DK128 on enhancing T helper type 1 immune responses and the efficacy of influenza vaccination in normal and CD4-deficient mice Vaccine Yu‐Jin Jung, Ki‐Hye Kim et al. 4
16 A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus Virology Youri Lee, Eun‐Ju Ko et al. 11
17 Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice Vaccine Eun‐Ju Ko, Youri Lee et al. 9
18 Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus Virology Ki‐Hye Kim, Young‐Tae Lee et al. 52
19 Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection Biochemical and Biophysical Research Communications Yu-Jin Kim, Eun‐Ju Ko et al. 17
20 Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection Virology Young‐Tae Lee, Ki‐Hye Kim et al. 20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026